Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Voting Common Stock	Non-voting Common Stock	Common Stock Voting Common Stock	Common Stock Non-voting Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Balances at Dec. 31, 2022	$ 99,434			$ 2	$ 1	$ 257,810		$ (158,379)
Balances, shares at Dec. 31, 2022				19,082,820	5,143,134
Exercise of stock options	711					711
Exercise of stock options, shares				316,441
Issuance of common stock, net of offering costs	42,414			$ 2		42,412
Issuance of common stock, net of offering costs, shares				23,287,134
Issuance of pre-funded warrants, net of offering costs	92,318					92,318
Conversion of non-voting common stock to voting common stock, shares				866,546	(866,546)
Stock-based compensation expense	5,208					5,208
Net loss	(89,218)							(89,218)
Balances at Dec. 31, 2023	150,867			$ 4	$ 1	398,459		(247,597)
Balances, shares at Dec. 31, 2023		43,552,941	4,276,588	43,552,941	4,276,588
Exercise of stock options	1,717					1,717
Exercise of stock options, shares				586,081
Issuance of common stock under employee stock purchase plan	333					333
Issuance of common stock under employee stock purchase plan, shares				82,153
Issuance of common stock, net of offering costs	33,131			$ 1		33,130
Issuance of common stock, net of offering costs, shares				4,958,068
Issuance of pre-funded warrants, net of offering costs	158,071					158,071
Conversion of convertible debt	14,750					14,750
Conversion of convertible debt, shares				3,134,796
Stock-based compensation expense	9,549					9,549
Net loss	(127,499)							(127,499)
Unrealized gain on available-for-sale securities	51						$ 51
Balances at Dec. 31, 2024	$ 240,970			$ 5	$ 1	$ 616,009	$ 51	$ (375,096)
Balances, shares at Dec. 31, 2024		52,314,039	4,276,588	52,314,039	4,276,588